Intravenous immunoglobulin in the Guillain-Barré syndrome. Products with low IgA content may be used in patients with total IgA deficiency.

Capa:Intravenous immunoglobulin in the Guillain-Barré syndrome. Products with low IgA content may be used in patients with total IgA deficiency.

Autor(es): Misbah S.


Imprenta: BMJ, v. 313, n. 7069, p. 1400, 1996


Identificador do objeto digital: 10.1136/bmj.313.7069.1400


Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies


Data de publicação: 1996